hematological malignancies
- United States
Invivoscribe Announces Key Submission in the EU, Expanded Presence and Activity in China
San Diego, United States: Invivoscribe, Inc., an industry pioneer in developing and commercializing diagnostic products and reagents for hematological malignancies,…
Read More »